查詢結果分析
相關文獻
- Feasibility of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Peritoneal Carcinomatosis from Colorectal Cancerin Short-term Outcome
- Long Term Disease Free Survival in a Patient with Pseudomyxoma Peritonei after Regionally Aggressive Management
- 結核性腹膜炎與腹膜轉移癌臨床表徵及一般性檢查之差異
- 接受腹腔內化學治療卵巢癌患者的症狀困擾與照護
- Applying F-18 Fluorodeoxyglucose-PET/CT to Identify Ovarian Cancer in a Patient with Peritoneal Carcinomatosis from Unknown Primary Site
- Omental Caking on Tc-99m MDP Bone Scan
- □F-FDG PET/CT Findings of Omental Cake: A Case Report
- Prognosis for Patients with Peritoneal Metastases-only Colorectal Cancer after Systemic Therapy: An Institutional Experience
- 淺談腹腔內化療
- 溫熱式腹內化學治療和細胞減積手術在大腸直腸癌合併腹膜轉移病人之照護
頁籤選單縮合
題 名 | Feasibility of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Peritoneal Carcinomatosis from Colorectal Cancerin Short-term Outcome=大腸直腸癌合併腹膜內轉移之病人接受腹腔內高溫化學治療的可行性與短期預後 |
---|---|
作 者 | 凌茂盛; 梁金銅; 黃約翰; 林本仁; | 書刊名 | 中華民國大腸直腸外科醫學會雜誌 |
卷 期 | 28:1 2017.03[民106.03] |
頁 次 | 頁27-33 |
分類號 | 416.245 |
關鍵詞 | 腹腔內化學治療; 腹膜轉移; Peritoneal carcinomatosis; Intraperitoneal chemotherapy; |
語 文 | 英文(English) |
中文摘要 | 目的 本研究之目的對於大腸癌腹膜內轉移的病人,在進行腹膜內高溫化學治療後之合併症與短期內追蹤之情形。方法 收集於西元2015 年7 月至2016 年4 月間,大腸直腸癌合併腹膜內轉移之患者於台大醫院進行腹膜內高溫化學治療至少一小時。總共包括22 名病患,針對其術後狀況進行分析。結果 在這22 名病患中,共有18 名病人接受了腫瘤廓清手術。在追蹤的期間內,5 名(22.7%) 病人在術後死亡;術後的併發症包括腸皮廔管 (13.6%)、吻合處滲漏 (9.1%)、肋膜積液 (9.1%)、輸尿管狹窄 (4.5%)、以及腸-膀胱廔管 (4.5%)。結論 實施腹膜內高溫化學治療術後的病人其併發症仍可在接受範圍內。 |
英文摘要 | Purpose. Cytoreductive surgery combined with intraperitoneal chemotherapy has been used to treat colorectal cancer with peritoneal carcinomatosis. In this study, we assessed the short-term surgical outcomes of hyperthermic intraperitoneal chemotherapy. Methods. Twenty-two patients with peritoneal cancer metastasis who were receiving HIPEC therapy were included in this study. A cytoreductive procedure was performed before HIPEC therapy for most patients. In addition, we used a closed system with FOLFOX or irinotecan + oxaliplatin as a chemotherapy regimen for at least 1 hour. Results. The mean age of patients was 59.59 ± 10.99 years, and their mean peritoneal cancer index was 10.27 ± 6.06. Eighteen of the twenty-two patients received a cytoreductive procedure. During the follow-up period, 5/22 (22.7%) patients died because of disease progression. The complications included enterocutaneous fistula (13.6%), anastomosis leakage (9.1%), pleural effusion (9.1%), ureteral stricture (4.5%), and entero-vesicle fistula (4.5%). Conclusions. The complication rate of hyperthermic intraoperative chemotherapy therapy was acceptable to the patients with peritoneal metastasis. |
本系統中英文摘要資訊取自各篇刊載內容。